Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin αvβ₃ as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Periostin (Postn) is shown to be required for alternative (less inflammatory) activation of microglia in brain tumors (Zhou et al., 2015).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Research works printed but not linked: 1
- Cheng L Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell 153 139 152 2013 23540695 PMC3638263
Cited by
Items 701–800 of 942
Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome
Alfino, L., Wilczewski‐Shirai, K. C., Cronise, K. E., Coy, J. W., Glapa, K. E., Ehrhart, E. J., Charles, J. B., Duval, D. L., & Regan, D. P. (2021) · Veterinary Pathology · doi:10.1177/0300985821996671 · Cited by 5
“Periostin is known to activate numerous signal transduction pathways including focal adhesion kinase (FAK) and phosphatidylinositol 3-kinase (PI3-K)/Akt, pathways which have all been implicated in cancer development and are known to be important for angiogenesis and cellular survival, proliferation, and migration.(1,8…”
BackgroundProspects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
Tietze, S., Michen, S., Schackert, G., & Temme, A. (2021) · Innovative Surgical Sciences · doi:10.1515/iss-2020-0034 · Cited by 4
“Additionally, the CXCL12/CXCR4 axis increases tumor aggressiveness [39] and together with secreted CCL7/MCP-3 [40], granulocyte–macrophage colony stimulating factor (GM-CSF) [41] and CX3CL1 (fractaline) [42] as well as increased levels of the extracellular matrix component periostin [43] is thought to result in GBM-in…”
BackgroundTargeting the molecular mechanisms of glioma stem cell resistance to chemotherapy
Fares, J., Kanojia, D., Cordero, Á., Ulasov, I. V., & Lesniak, M. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00014-2 · Cited by 6
Ren, W., Jin, W., & Liang, Z. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.832944 · Cited by 4
“In the GBM tissues, tumor-associated macrophages mainly originated from the peripheral blood monocytes, and M2 polarization was induced by ARS2/MAGL signals from the tumor stem cells (26, 27).”
BackgroundJain, H., Dhawan, P., Rao, S., Lalwani, N., & Shand, H. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220901101204 · Cited by 4
Luo, Y., Wang, K., Zhan, L., Zeng, F., Zheng, J., Chen, S., Duan, X., & Ju, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1214413 · Cited by 5
“…associated with immune in fi ltration in glioblastoma. b 3GNT9 expression was positively associated with the in fi ltration levels of CD4+T cells, macrophages, dendritic cells ( P <0.05), but negatively correlated with tumor purity, B cells, CD8+T cells, and neutrophils ( P <0.05). glioblastoma (33).”
BackgroundInfluentialShido, K., Fujimura, T., Kakizaki, A., Furudate, S., Asano, M., & Aiba, S. (2016) · Case Reports in Dermatology · doi:10.1159/000444045 · Cited by 4
Molekularne podłoże oddziaływania komórek nowotworowych z mikrośrodowiskiem w glejakach złośliwych
Ellert‐Miklaszewska, A., Pasierbińska, M., Poleszak, K., & Kamińska, B. (2018) · Postępy Biochemii · doi:10.18388/pb.2018_123 · Cited by 6
Attenuation of periostin in retinal Müller glia by TNF-α and IFN-γ
Peng, Y., Cao, M.-J., Yoshida, S., Zhang, L.-S., Zeng, H.-L., Zou, J.-L., Kobayashi, Y., Nakama, T., Shi, J.-M., Jia, S.-B., et al. (2019) · International Journal of Ophthalmology · doi:10.18240/ijo.2019.02.05 · Cited by 4
Periostin as a biomarker of airway inflammation
McSharry, C. P., & Johnstone, S. A. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3333 · Cited by 4
Geczi, D. A., Klekner, Á., Balogh, I., Penyige, A., Szilágyi, M., Virga, J., Bako, A. A., Nagy, B., Torner, B., & Birkó, Z. (2025) · Pharmaceuticals · doi:10.3390/ph18030431 · Cited by 4
“Periostin (POSTN) is a secreted extracellular matrix protein that plays a role in attracting M2-type tumor-associated macrophages (TAMs), which are monocyte-derived macrophages from peripheral blood, to facilitate the growth of GBM [74].”
Harnessing the innate immune system for glioblastoma therapeutics
McLean, H., Drill, M., Sequeira, R. P., Jayakrishnan, P. C., Jeffree, R. L., Hunn, M., O'Brien, T. J., Hamilton, J., & Monif, M. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578713 · Cited by 3
“Interestingly, many of these factors have been shown to not only recruit monocytes, macrophages and microglia, but also instruct these immune cells to release immunosuppressive cytokines and support GBM cancer cell growth (Tao et al., 2020; Zhou et al., 2015; Wu et al., 2010).”
Cui, Y., Phuong, K., Abdelfattah, N. S., Temple, H. M., Maiorino, L., Kim, B., Dye, J., Yu, K. K. H., Spranger, S., Irvine, D. J., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4674 · Cited by 4
Neuropeptide adrenomedullin remodels stemness and macrophage dynamics in glioblastoma
Ali, H. A., Khan, F., Xuan, W., Liu, Y., Huang, Y., Whitfield, D., Pang, L., & Chen, P. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116342 · Cited by 4
Gong, S., Shang, M., Li, S., Ding, X., Cai, Y., Jin, J., & Yang, Z. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503437 · Cited by 4
Xie, C., Yin, J. J., & Zhu, J. (2025) · Phytotherapy Research · doi:10.1002/ptr.70138 · Cited by 4
Xu, H., Zhao, X., & Luo, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05300-5 · Cited by 7
“GBM exhibits reduced numbers of effective tumor-infiltrating CD8 + T lymphocytes and the presence of multiple immunosuppressive cell populations, such as tumor-associated macrophages (TAMs) [61, 62], regulatory T cells (Tregs) [63], and myeloid-derived suppressor cells (MDSCs) [64, 65] in the TME.”
BackgroundRichard, S. A., Roy, S. K., & Asiamah, E. A. (2024) · Clinical Medicine Insights Oncology · doi:10.1177/11795549241282098 · Cited by 3
“33”
BackgroundReciprocal interactions between glioma and tissue-resident cells fueling tumor progression
Laurenge, A., Castro‐Vega, L. J., & Huberfeld, G. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00007-7 · Cited by 4
Chen, Z., Zhang, S., Jiang, C., Jiang, L., Chen, H., Huang, J., Liu, J., Yang, G., Luo, X., Chi, H., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-02431-4 · Cited by 4
“Subsequently, we substantiated the impact of each subtype on GB”
Wang, M., Gui, C., Qiu, S., Tang, J., & Peng, Z. (2017) · Cytotechnology · doi:10.1007/s10616-017-0141-0 · Cited by 3
Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment
Wei, J., Gilboa, E., Călin, G. A., & Heimberger, A. B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682129 · Cited by 4
Prognostic Impact of the Angiogenic Gene POSTN and Its Related Genes on Lung Adenocarcinoma
Sun, D., Gai, Z., Wu, J., & Chen, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.699824 · Cited by 4
“As a gene with survivorship differences, POSTN can induce the accumulation of tumor-associated macrophages around the tumor cells and may play a supportive role for TAMs in tumor progression (52).”
BackgroundYang, D., Xue, C., Bu, X., Yan, Z., Qu, M., Zhao, Y.-W., Kong, L., Wang, Y.-W., & Luo, J.-C. (2022) · Technology and Health Care · doi:10.3233/thc-220194 · Cited by 3
Luo, S., Wang, J., & Gao, M. (2024) · Journal of Biomaterials Applications · doi:10.1177/08853282241268694 · Cited by 3
“12 Meanwhile, studies have shown that the secretion of M1-type microglia can promote the re-transformation of M2-type cells into M1-type cells, thereby achieving tumor rupture.”
Radiation Oncology in Glioblastoma (GBM)
Desideri, I., Nardone, V., Morelli, I., Gagliardi, F., & Minniti, G. C. (2024) · Springer eBooks · doi:10.1007/978-3-031-59341-3_7 · Cited by 3
Morusin regulates the migration of M2 macrophages and GBM cells through the CCL4-CCR5 axis
Zhao, Y., Zhou, X., Hong, L., Pan, J., Pan, J., Shafi, S., Siraj, S., Ahmad, N., Liu, J., Zhao, R., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113915 · Cited by 3
Zhao, K., Ma, Y., Luo, J., Xu, Y., Shou, Q., Jiang, H., & Zhu, X. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2450246 · Cited by 3
“As the tumor progresses, M1 macrophages polarize towards the M2 macrophages in response to some signals in the TME (Zhou et al., 2015).”
Oncostreams organize peritumoral glioma infiltration
Lowenstein, P. R. (2025) · Nature Cancer · doi:10.1038/s43018-025-01022-0 · Cited by 3
Multimodality Targeting of Glioma Cells
He, Z., Mitteer, R. A., Mou, Y., & Fan, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47660-7.00005-7 · Cited by 6
HOXC8: a predictive glioma biomarker that induces epithelia-mesenchymal transition
Liang, T., Wang, X., Li, P., Cao, Y., Feng, E., & You, G. (2018) · Chinese Neurosurgical Journal · doi:10.1186/s41016-018-0132-9 · Cited by 3
Choi, Y., Oh, H., Ahn, M., Kang, T., Chun, J.-Y., Shin, T., & Kim, J. (2020) · Journal of Veterinary Medical Science · doi:10.1292/jvms.20-0225 · Cited by 4
“Periostin, also referred to as osteoblast-specific factor (OSF)-2, is the representative extracellular matrix component secreted primarily by fibroblasts and macrophages [21].”
BackgroundXu, P., Sun, X., Song, X., Peng, Y., He, B., Zheng-dong, W., & Zhu, J. (2021) · Medicine · doi:10.1097/md.0000000000024449 · Cited by 3
“Monocytes in the circulation can be recruited to tumor tissues by various tumor-secreted chemokines.([37]) To examine the predictive value of the LMR and G9a, they were included in a multivariate analysis.”
BackgroundBlood Vessels in the Brain: A Signaling Hub in Brain Tumor Inflammation
Guérit, S., & Liebner, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-45514-3_11 · Cited by 3
Rousseau, J., Bertholon, C., Chapurlat, R. D., & Szulc, P. (2019) · Bone · doi:10.1016/j.bone.2019.115184 · Cited by 3
Kalimuthu, S., Gangadaran, P., Oh, J. M., Rajendran, R. L., Lee, H., Gopal, A., Hong, C. M., Jeon, Y. H., Jeong, S. Y., Lee, S., et al. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1745817 · Cited by 3
“CSC growth is attributed to therapy resistance, immune evasion, cancer invasion, angiogenesis, and recruitment of tumour macrophages for facilitating cancer growth [10 – 12].”
Ling, H., Yang, Z. H., Sun, Y., He, Y., Ju, S., Li, J., & Fu, J. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.97355 · Cited by 4
“Current knowledge of exosomes shows that they play an important role in the development and progression of cancer, modulate intercellular communication within the TME by transferring proteins, lipids, and genetic content [11, 12], and promote the M2 phenotypic functional polarisation of TAMs [13].”
BackgroundHuang, Z., Zhai, K., Wu, Q., Fang, X., Huang, Q., Tao, W., Lathia, J. D., Yu, J. S., Rich, J. N., & Bao, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.09.447550 · Cited by 3
Darvish-Damavandi, M., Zhou, Y., & Buczacki, S. J. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00076-6 · Cited by 3
Raguin, J., Kortulewski, T., Bergiers, O., Granotier, C., Chatrousse, L., Benchoua, A., Gauthier, L., Boussin, F. D., & Mouthon, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.28.625826 · Cited by 3
Prognostic signature detects homologous recombination deficient in glioblastoma
Luo, D., Luo, A., Hu, S., Zhao, H., Yao, X., Li, D., & Peng, B. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2077 · Cited by 2
“Silencing POSTN can visibly reduce tumor-associated macrophages, thereby inhibiting tumor growth in xenografts (63).”
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma
Konda, P., Wakolbinger, A. J., Cui, Y., Oliveira, G. R. D., Laimon, Y. N., Weiss, C. N., Seager, M. D., Deodhar, R., Li, J., Matar, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76858-w · Cited by 2
Fang, W., Zou, Q., Sun, Q., Jiang, T., Cai, T., Li, X., & Xie, K. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101859 · Cited by 2
Small-molecule therapies targeting tumor-associated macrophages in glioma: mechanisms and potential
Wang, H., Luo, H., Zhong, H., Ockleton, A., Jiang, F., Yi, R., Yang, S., & Li, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115734 · Cited by 3
Mishra, J., Dickinson, J. D., & Maurya, S. K. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1666837 · Cited by 4
Guo, M., Luo, W., Ling, P., Lei, H., Li, L., Duan, C., Xue, Z., Zhang, M., Zhang, X., Bao, W., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-67418-9 · Cited by 2
“GSCs and NSTCs were isolated from primary GBM tumors or patient-derived xenografts and func-tionallycharacterized 19,50,51 .”
Wadhonkar, K., Das, D., Chittela, R. K., Obukhov, A. G., & Baig, M. S. (2025) · Carcinogenesis · doi:10.1093/carcin/bgag003 · Cited by 3
Zhu, H., Cheng, L., Liu, D., Ma, Y., Fan, H., He, S., Liang, W., Mei, D., Ma, X., Li, R. H., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03930-z · Cited by 3
“Under the approval of the Medical Ethics Committee of Tongji Hospital, peripheral blood mononuclear cells (PBMCs) were isolated from donor blood using density gradient centrifugation as previously reported [9].”
Periostin: A Potential Target for Glioblastoma Multiforme Treatment
Cavaleri, J., & Monaco, E. A. (2015) · Neurosurgery · doi:10.1227/01.neu.0000465856.13744.2d · Cited by 2
PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
Qiao, H., & Li, H. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s425251 · Cited by 3
“…large number of factors that stimulate tumor growth and invasion and increase the invasion of glioma stem cells that promote tumour vascularity, 110,111 and it has been demonstrated that the number of macrophages in the perivascular area correlates positively with the density of capillaries in the…”
BackgroundSteijvers, E., Shi, Y., Lu, H., Zhang, W., Zhang, Y., Zhao, F., Wang, B., Hughes, L. C., Barralet, J. E., Degli-Alessandrini, G., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.11.025 · Cited by 4
“Osteogenic stem cells have been identified on the periosteal bone surface [23 – 26].”
Challenges and Emerging Strategies of Immunotherapy for Glioblastoma
Mao, M., Yao, L., Ma, X., & Xie, H. (2025) · ChemBioChem · doi:10.1002/cbic.202400848 · Cited by 3
A history of exploring cancer in context
Maman, S., & Witz, I. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0024-x · Cited by 5
Highlights from the Literature
Huse, J. T., Abounader, R., Purow, B. W., Hegi, M. E., Soffietti, R., & Aldape, K. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now215 · Cited by 2
(2018) · Precision Medicine · doi:10.14800/pm.1097 · Cited by 2
“To determine other biological changes in the microenvironment of infected macrophages and glioma cells, we also examined the expression of EGFR that usually plays an important role in GBM progression.”
BackgroundInfluentialPoole, A., Lun, X. Q., Robbins, S. M., & Senger, D. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821310-0.00009-7 · Cited by 2
Pineal Gland Tumor Microenvironment
Choque‐Velasquez, J., Baluszek, S., Colasanti, R., Muhammad, S., & Hernesniemi, J. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_8 · Cited by 3
Signaling in the tumor microenvironment of therapy-resistant glioblastoma
Nikolopoulos, M., & Das, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00004-x · Cited by 2
He, D., Qin, Z., Liu, Z., Ji, X., Gao, J., Guo, H., Yang, F., Fan, H., Wei, Y., Wang, Z., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.816760 · Cited by 2
Tanita, K., Fujimura, T., Kakizaki, A., Furudate, S., Mizuashi, M., Watabe, A., & Aiba, S. (2016) · Case Reports in Dermatology · doi:10.1159/000444162 · Cited by 2
Cancer Stem Cells and the Development of Cancer
Ghoneim, N. I., Mohamed, R. H., Gamal, A., Magdy, S., & El‐Badri, N. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-55359-3_5 · Cited by 2
Baker, G. J., Muhlich, J. L., Palaniappan, S. K., Moore, J. K., Davis, S. H., Santagata, S., & Sorger, P. K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/555854 · Cited by 2
“1 n/a #VALUE! #VALUE! #VALUE! blood naïve (6) 0.”
MethodInfluentialXu, H., Li, T., Wang, C., Ma, Y., Liu, Y., Zheng, M.-Y., Liu, Z. J. Y., Chen, J., Li, K., Sun, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-715564/v1 · Cited by 2
Taiwo, R., Mahlokozera, T., & Kim, A. H. (2018) · Stem Cell Investigation · doi:10.21037/sci.2018.07.01 · Cited by 4
Ellert‐Miklaszewska, A., Pilanc, P., Poleszak, K., Roura, A.-J., Cyranowski, S., Ghosh, M., Baluszek, S., Pasierbińska, M., Gielniewski, B., Swatler, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.06.606798 · Cited by 2
Immunomodulatory roles of myeloid cells in gliomas
Chuntova, P., Watchmaker, P. B., Gilbert, R., & Okada, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819755-4.00010-2 · Cited by 1
Cancer stem cells and clonal evolution in bone sarcomas
Rodríguez, R., Hatina, J., Gambera, S., Menéndez, S. T., & García-Castro, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00010-4 · Cited by 3
Global research trends in tumor-associated macrophage studies: a bibliometric analysis
Luan, A., Zhang, Y., Lu, Y., Zhao, G., & Yang, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02473-8 · Cited by 2
“As the tumor progresses, cues from the TME can drive macrophages toward an M2-like phenotype [22–24].”
Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1
Pulh, P., Coulpier, F., Onfroy, A., Oubrou, L., Zhang, W., Toledano, L. M. C., Zougheib, E. A., Fertitta, L., Wolkenstein, P., & Topilko, P. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02075-z · Cited by 1
“POSTN can also recruit M2 macrophages [2, 36, 38] and directly interact with sensory neurons to induce itching [19, 20].”
Zhang, L., Chen, W., Huang, W., & Cheng, H. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl42844 · Cited by 1
Innate immune cells in oral squamous cell carcinoma: Characteristics and therapeutic potential
Jiang, Y., Cheng, J., Wu, J., Liu, O., & Bin, X. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189444 · Cited by 3
Regulation of Cancer Stem Cells in the Tumor Microenvironment
Li, A., Li, N., Yang, Y., Wang, L., Miao, J., & Wang, Q.-E. (2025) · Cancer Heterogeneity and Plasticity · doi:10.47248/chp2502040016 · Cited by 1
“For example, in GBM, CSCs preferentially express periostin (POSTN) to recruit monocytes to the tumor site and promote polarization to an M2, tumor-promoting state via integrin α v β 3 signaling, a finding recapitulated in ICC [80,81].”
Xu, X., Li, Y., He, S., Wen, F., Guo, N., & Wu, S. (2025) · Medicine · doi:10.1097/md.0000000000045858 · Cited by 1
Xiao, J.-F., Ishaya, K., Ko, E. Y., Fowler, A., Broz, M. T., & Guarnerio, J. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0301 · Cited by 2
Ma, K., Liu, Z., Chai, S., Fang, Q., Xu, R., Zhu, W., Liu, Y., Zhang, T., Guo, Z., Cui, C., et al. (2026) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2026.102936 · Cited by 1
Raguin, J., Legrand, N., Kortulewski, T., Bergiers, O., Granotier-Beckers, C., Chatrousse, L., Benchoua, A., Gauthier, L., Boussin, F. D., & Mouthon, M. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101425 · Cited by 7
“43 Interactions between cancer cells and immune cells are known to drive transition to mesenchymal-like states in GBM. 44 Our model allows for the specific investigation of how GSCs influence microglial cells.”
InfluentialRahimi, A., Solgi, G., Safarzadeh, M., Mohammadi, P., & Rastegari‐Pouyani, M. (2026) · Cancer Gene Therapy · doi:10.1038/s41417-026-01040-9 · Cited by 1
“For example, CSCs are capable of recruiting TAMs with M2 phenotype (pro-tumor TAMs) through periostin secretion [84].”
Tan, J., Wen, T., Liu, J. S., & Ru, X. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01828-0 · Cited by 2
“Additional evidence is that glioblastoma stem cells secrete periostin to recruit M2-like TAMs and support malignant growth [280].”
Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets
Lu, Y., Shao, D., Xiao, Y., Jiang, Y., & Shao, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02851-w · Cited by 5
New Avenues in Radiotherapy of Glioblastoma: from Bench to Bedside
Gouazé‐Andersson, V., & Moyal, E. C. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-00654-0 · Cited by 2
SEIZURES IN CHILDREN WITH LOW GRADE GLIOMA
Ostwal, P., & Nandan, S. (2020) · MNJ (Malang Neurology Journal) · doi:10.21776/ub.mnj.2021.007.01.12 · Cited by 1
Advances in research on glioma microenvironment and immunotherapeutic targets
Tang, A., Liang, J., Mai, Y., & Sun, H. (2022) · Journal of Cancer Discovery · doi:10.55976/jcd.1202218514-29 · Cited by 3
“In turn, GSCs enhance TAM trafficking and M2 polarization through paracrine periostin and osteopontin [25-27].”
BackgroundMolecular Genetic Aspects of Gliomas Development and Progression: A Literature Review
As, F., Боровский, А. А., Давидян, А. В., Шамкалович, А. В., & Veevnik, D. P. (2022) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2022.12.3.036 · Cited by 1
Wang, S. S. Y. (2023) · Tumori Journal · doi:10.1177/03008916231158411 · Cited by 1
“71 The glioma CSCs secreted cytokines such as M Φ inhibitory cytokine-1 (MIC-1) and transforming growth factor (TGF-β 1).”
BackgroundJiang, Q., Ling, G., Yan, J., Tan, J.-Y., Nong, R.-B., Li, J., Deng, T., Mo, L., & Huang, Q. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101605 · Cited by 3
“Currently, targeting macrophages has good application prospects in the treatment of glioma [53,54].”
BackgroundChang, R., & Li, Y. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3021651 · Cited by 1
“Their team used nanomaterial to create a membrane to give the nanoparticles tropistic property to produce a tumor-homing immune nanoregulator (THINR) (Zhang J. et al., 2021; Zhou W et al., 2015) that could improve the immunotherapy [15, 17].”
MethodEtomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization
Gao, C., & Nie, Y. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-023-01335-y · Cited by 1
“Besides, research also showed that periostin secreted by glioma stem cells recruits M2 type of tumor-associated macrophages to promote glioblastoma growth (Zhou et al. 2015).”
Li, G., Chen, Y., Hu, Y., Zhao, W., Lu, Y.-Y., Wan, F., Wu, Z., Wang, X., & Yu, Q. (2024) · Aging · doi:10.18632/aging.205715 · Cited by 2
Xiong, Z., Sneiderman, C. T., Kuminkoski, C. R., Reinheimer, J., Schwegman, L., Sever, R. E., Habib, A., Hu, B., Agnihotri, S., Rajasundaram, D., et al. (2025) · Genes and Immunity · doi:10.1038/s41435-025-00326-6 · Cited by 2
Cancer Stem Cells and Tumor-Associated Macrophages
Zhou, W., & Bao, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803892-5.00014-0 · Cited by 1
Prostate Apoptosis Response-4: a Therapeutic Target for Malignant Gliomas
Ghosalkar, J., Sonawane, V. R., Khan, M., Joshi, K. S., & Shastry, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-80558-6_6 · Cited by 2
Role of the Extracellular Matrix in Tumor Stroma: Barrier or Support?
Zeltz, C., Navab, R., Lü, N., Kusche‐Gullberg, M., Tsao, M., & Gullberg, D. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_5 · Cited by 2
Updates in Vaccines, Viral Therapy and Non-Lymphocytic Immunotherapy for Glioblastoma
Wu, A., Jackson, C. M., & Lim, M. K. (2016) · International Journal of Clinical Therapeutics and Diagnosis · doi:10.19070/2332-2926-1600023 · Cited by 1
“A proposed mechanism of the pro-tumor growth influence of M2-type macrophages in the tumor microenvironment has been the secretion of chemokine periostin by glioblastoma stem cells [GSC], which leads to the recruitment and maintenance of M2-type TAMs as well as other monocyte derivatives [71].”
BackgroundGan, C., Li, M., Peng, G., Li, W., Wang, H., Peng, Y., Hu, Q., Wei, W., Wang, F., Liu, L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-81480/v2 · Cited by 1
Hou, X., Zhou, G., Fan, Y., Zhang, Q., Xiang, C., Cao, F., & Yao, S. (2020) · doi:10.21203/rs.3.rs-31174/v2 · Cited by 1
Li, M., Li, W., Wang, H., Peng, Y., Hu, Q., Wei, W., Gan, C., Wang, F., Liu, L., & Zhao, Q. (2020) · Research Square · doi:10.21203/rs.3.rs-81480/v1 · Cited by 1
Hou, X., Zhou, G., Fan, Y., Zhang, Q., Xiang, C., Cao, F., & Yao, S. (2020) · doi:10.21203/rs.3.rs-31174/v1 · Cited by 1
Nabbi, A., Beck, P., Delaidelli, A., Oldridge, D. A., Sudhaman, S., Zhu, K., Yang, S., Mulder, D. T., Bruce, J. P., Paulson, J. N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.20.508719 · Cited by 1
“EDIL3 and POSTN encoding ligands for αVβ3 integrin (DEL-1 and periostin) were expressed at higher levels in MG3, the latter of which can recruit tumour-associated macrophages (TAM) in adult glioblastoma (104,105).”
BackgroundZarodniuk, M., Steele, A., Lü, X., Li, J., & Datta, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2931886/v1 · Cited by 1
“CXCL1, CXCL2, CXCL12, CSF1, and matricellular protein periostin (POSTN), which are known to induce chemotaxis and alternative polarization of tumor-supporting M2-like myeloid cells (Figure 3D-F) (Turley, Cremasco, and Astarita 2015; Sánchez-Martín et al. 2011; Shi et al. 2018; Zhou et al. 2015; Stafford et al. 2016; F…”
BackgroundZhang, Y. Q., He, H., Fu, X., Liu, G., Wang, H., Zhong, W., Chen, B., & Xu, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4895325 · Cited by 1
Metadata
- Authors
- Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S.
- Affiliations
- Cleveland Clinic (US)
- University Hospitals Cleveland Medical Center (US)
- Duke Medical Center (US)
- Corresponding author
- Bao, Shideng
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-01-12
- Volume
- 17
- Issue
- 2
- Pages
- 170-182
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4312504
- OpenAlex
- W2073586533
- Cited by
- 940
- References
- 67
- Citations by year
- 2026: 29 · 2025: 74 · 2024: 93 · 2023: 101 · 2022: 118 · 2021: 117 · 2020: 93 · 2019: 82 · 2018: 71 · 2017: 81 · 2016: 50 · 2015: 30
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cleveland Clinic
- National Institutes of Health (1r01ns071996-01a1)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Allergy and Infectious Diseases (T32AI089474)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, R01NS070315)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- periostin, glioblastoma, glioma stem cells, tumour-associated macrophages, M2 macrophages, macrophage recruitment, integrin αvβ3, RGD peptide, monocyte-derived macrophages, tumor microenvironment, tumor growth, therapeutic target
- MeSH terms
- Animals, Brain Neoplasms, Cell Count, Chemotactic Factors, Female, Fluorescent Antibody Technique, Glioblastoma, Humans, Luminescent Measurements, Macrophages, Mice, Inbred C57BL, Monocytes, Neoplastic Stem Cells, Signal Transduction, Cell Adhesion Molecules, Survival Analysis, Gene Silencing, Xenograft Model Antitumor Assays, RNA, Small Interfering, Integrin alphaVbeta3, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.